EQ - Equillium, Inc.
0.384
-0.007 -1.693%
Share volume: 50,680
Last Updated: 05-12-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.39
-0.01
-0.02%
View ratios
| Fiscal Date | 12-31-2024 | |
|---|---|---|
| Fiscal Quarter | Q4 2024 | |
| Report Date | 03-27-2025 | |
| Total revenue | 4.392 M | |
| Cost of revenue | 0.000 | |
| Gross profit | 4.392 M | |
| Operating expenses | 9.091 M | |
| Selling general and admin | 1.776 M | |
| Research and development | 7.315 M | |
| Total expenses | 9.091 M | |
| Operating income | -4.699 M | |
| Ebit | -5.673 M | |
| Pretax income | -5.433 M | |
| Income tax | 361.000 K | |
| Net income basic | 0.000 | |
| Net income | -5.794 M | |
